Navigation Links
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH

ProductsMynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Company Minerva Biolabs GmbH
Item Mynox Mycoplasma Elimination Reagent
Price 
Description Mynox is the first biological reagent that eliminates mycoplasmas by killing them, and not just by inhibiting growth. Mynox is the only anti-mycoplasma agent that can be used to clean virus stocks directly. The cytotoxicity of Mynox is extremely low.
Info Minerva Biolabs GmbHMinerva Biolabs GmbH
Minerva Biolabs GmbH
Kpenicker Strasse 325
D-12555 Berlin
Germany
Customer Service: +49 (0)30 6576 2830
Fax Number: +49 (0)30 6576 2831
Web Site: http://www.minerva-biolabs.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mynox Mycoplasma Elimination Reagent from Sigma-Aldrich
2. Mycoplasma Testing from AbD Serotec
3. Mycoplasma Testing from AbD Serotec
4. Mycoplasma IgG ELISA Kit, Single from Bio-Quant Inc.
5. Mycoplasma IgM ELISA Kit, Single from Bio-Quant Inc.
6. Mycoplasma Testing and Decontamination from Covance Research Products, Inc
7. Cleland’s Reagent from Calbiochem
8. Cleland’s Reagent, ULTROL® Grade from Calbiochem
9. GenomONE-Neo EX HVJ-E 4 vial(s) Transfection Reagents from Cosmo Bio Co., Ltd.
10. Cleland’s Reagent, Molecular Biology Grade from Calbiochem
11. Cleland’s Reagent from Calbiochem
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
Breaking Biology Technology: